These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1688481)

  • 1. Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available.
    Morganroth J; Bigger JT; Anderson JL
    Am J Cardiol; 1990 Jan; 65(1):40-8. PubMed ID: 1688481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(4):36B-42B. PubMed ID: 2105050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial.
    Anderson JL
    J Clin Pharmacol; 1990 Nov; 30(11):981-9. PubMed ID: 2122984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic agents in older patients. Current state of knowledge.
    Kim CH; Daubert JP; Akiyama T
    Drugs Aging; 1994 Jun; 4(6):462-9. PubMed ID: 7521233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
    Steinbeck G; Andresen D; von Leitner ER
    Z Kardiol; 1986; 75 Suppl 5():47-55. PubMed ID: 2435071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio.
    Pratt CM; Eaton T; Francis M; Woolbert S; Mahmarian J; Roberts R; Young JB
    Am Heart J; 1989 Sep; 118(3):433-40. PubMed ID: 2476016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockers in combination with class I antiarrhythmic agents.
    Deedwania PC; Olukotun AY; Kupersmith J; Jenkins P; Golden P
    Am J Cardiol; 1987 Aug; 60(6):21D-26D. PubMed ID: 2442991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias.
    Cain ME
    Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-benefit profiles of antiarrhythmic therapy.
    Campbell RW; Nimkhedkar K
    Am J Cardiol; 1989 Dec; 64(20):50J-52J. PubMed ID: 2480709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Aug; 60(6):10D-14D. PubMed ID: 2888297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the university cardiologist treats ventricular premature beats: a nationwide survey of 65 University Medical Centers.
    Vlay SC
    Am Heart J; 1985 Oct; 110(4):904-12. PubMed ID: 4050669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.